Page last updated: 2024-09-04

febuxostat and Familial Hypokalemia-Hypomagnesemia

febuxostat has been researched along with Familial Hypokalemia-Hypomagnesemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Arai, H; Ishimaru, Y; Kitamura, M; Maeda, K; Matsumura, K; Mori, T; Nishino, T; Obata, Y; Sohara, E; Uchida, S; Umene, R; Uramatsu, T	1

Other Studies

1 other study(ies) available for febuxostat and Familial Hypokalemia-Hypomagnesemia

Article	Year
Bartter syndrome representing digenic-based salt-losing tubulopathies presumably accelerated by renal insufficiency. CEN case reports, 2020, Volume: 9, Issue:4 Topics: Adult; Bartter Syndrome; Chloride Channels; Diagnosis, Differential; Drug Therapy, Combination; Febuxostat; Female; Gitelman Syndrome; Gout Suppressants; Heterozygote; Humans; Hyperuricemia; Hypokalemia; Mutation; Phenotype; Potassium Chloride; Renal Insufficiency; Solute Carrier Family 12, Member 1; Treatment Outcome	2020

Article

Year

Bartter syndrome representing digenic-based salt-losing tubulopathies presumably accelerated by renal insufficiency.

CEN case reports, 2020, Volume: 9, Issue:4

Topics: Adult; Bartter Syndrome; Chloride Channels; Diagnosis, Differential; Drug Therapy, Combination; Febuxostat; Female; Gitelman Syndrome; Gout Suppressants; Heterozygote; Humans; Hyperuricemia; Hypokalemia; Mutation; Phenotype; Potassium Chloride; Renal Insufficiency; Solute Carrier Family 12, Member 1; Treatment Outcome

2020